Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Ustekinumab helped three kids with alopecia areata regrow hair.

CS12192 effectively treats alopecia areata with better safety than current options.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Topical IKKα inhibitors may help prevent CCS tumours.

Low-dose topical alpha-terthienyl may be a safer option for treating skin conditions with light therapy.

Er:YAG laser therapy effectively treats Hailey-Hailey disease, leading to long-term remission and improved quality of life.

Blocking certain proteins on immune cells may help treat alopecia areata.

Deucravacitinib effectively treats psoriasis and may help with other skin conditions.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

The LED device safely improves neck skin appearance without affecting thyroid function.

Severe hypothyroidism can cause temporary liver and kidney issues, which improve with thyroxine treatment.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Deuruxolitinib effectively promotes hair regrowth in alopecia areata.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

A woman with severe hypothyroidism had a rare skin condition usually linked to a different thyroid disease.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

Talquetamab may cause hair loss and skin issues.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.